Nov 2 (Reuters) - Mimedx Group Inc MDXG.O :
* MIMEDX ANNOUNCES THIRD QUARTER 2022 OPERATING AND
FINANCIAL
RESULTS
* Q3 SALES ROSE 7.3 PERCENT TO $67.7 MILLION
* QTRLY LOSS PER SHARE $0.09
* EXPECTS NET SALES FOR Q4 2022 TO BE IN A RANGE OF $73 TO
$76
MILLION
* COMPANY EXPECTS FY NET SALES TO BE IN A RANGE OF $266 TO
$269
MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.08, REVENUE VIEW $66.7
MILLION --
REFINITIV IBES DATA
* FY2022 EARNINGS PER SHARE VIEW $-0.31, REVENUE VIEW $267.5
MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2TvG9d
Further company coverage: MDXG.O
((Reuters.Briefs@thomsonreuters.com;))